Study Summary
This trial is testing a new clinic that could help older stem cell transplant patients manage their side effects and other medical conditions.
Eligible Conditions
- Stem Cell Transplant Complications
- Lymphoma
- Multiple Myeloma
- Bone Marrow Transplant
Treatment Effectiveness
Study Objectives
5 Primary · 0 Secondary · Reporting Duration: Up to 100 days after transplant
Month 6
Length of transplant stay in days
Day 100
Readmission rates
at time of assessment (an average of 90 minutes)
Time to complete geriatric assessment clinic
Hour 1
Patient satisfaction as determined by "patient follow-up quesitonnaire"
Physician satisfaction as determined by "physician questionnaire"
Trial Safety
Trial Design
1 Treatment Group
Transplant Wellness Clinic
1 of 1
Experimental Treatment
20 Total Participants · 1 Treatment Group
Primary Treatment: Cancer Aging Research Group (CARG) assessment · No Placebo Group · N/A
Transplant Wellness ClinicExperimental Group · 9 Interventions: Cancer Aging Research Group (CARG) assessment, Cognitive Assessment, Nutrition assessment, Patient satisfaction questionnaire, Medication Review, physical therapy consult, Laboratory studies, Patient follow-up questionnaire, Physician Questionnaire · Intervention Types: Other, Other, Other, Other, Other, Other, Other, Other, Other
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 100 days after transplant
Who is running the clinical trial?
Case Comprehensive Cancer CenterLead Sponsor
428 Previous Clinical Trials
29,943 Total Patients Enrolled
Brenda H Cooper, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Kirsten M Boughan, DOPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Eligibility Criteria
Age Any Age · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:The text refers to people who are candidates for a particular type of transplant.
old
People who are candidates for stem cell transplants who are 60 years old or older.
.0
Patients who are younger and have an age adjusted HCT- CMI> 4.0 are more likely to respond to treatment.
The patient must have at least 4 weeks and a maximum of 12 weeks before the anticipated start of their transplant procedures, for example, the initiation of their preparation regimen or the beginning of their peripheral stem cell mobilization.
This person was seen as an outpatient when they enrolled in the study.
In order to attend outpatient appointments, one must have transportation.
forms and patient information
You must be able to read and understand English in order to complete the required questionnaires
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments